Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech
Under the terms of the agreement, Biotheus will grant BioNTech worldwide, exclusive options to a preclinical-stage bispecific antibody…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Jul 23
Under the terms of the agreement, Biotheus will grant BioNTech worldwide, exclusive options to a preclinical-stage bispecific antibody…
20 Jul 23
On 5 May 2023, France reported an increase in cases of severe neonatal sepsis associated with Enterovirus (Echovirus-11…
19 Jul 23
Safety, sustainability and regulation are three of the biggest challenges facing the food & beverage ingredient industry in…
19 Jul 23
The expanded partnership will see Teladoc integrating its Solo platform with Microsoft Azure OpenAI Service, Azure Cognitive Services,…
19 Jul 23
Under the agreement, Flagship and Pfizer will each invest $50m upfront to assess opportunities to develop 10 single-asset…
19 Jul 23
Emory Hernandez Valadez claims that heavy exposure to the company's talc starting in his early years led to…
19 Jul 23
The products involved in the deal include FLAREX, NATACYN, TOBRADEX ST, VERKAZIA, ZERVIATE, and non-prescription brands FRESHKOTE and…
19 Jul 23
The reorganisation will focus on consolidating functional roles within the group companies to strengthen various aspects, including business…
19 Jul 23
First multi-centre trial, EXCYTE-1, evaluating the potential of Exscientia’s functional precision medicine platform in solid tumour indication
19 Jul 23
In a Phase 2 study, navacaprant (NMRA-140) monotherapy demonstrated statistically significant and clinically meaningful reductions in symptoms of…